A phase II trial of JM-216 in cervical cancer: an NCIC CTG study.
Trudeau M, Stuart G, Hirte H, Drouin P, Plante M, Bessette P, Dulude H, Lebwohl D, Fisher B, Seymour L.
Trudeau M, et al.
Gynecol Oncol. 2002 Feb;84(2):327-31. doi: 10.1006/gyno.2001.6409.
Gynecol Oncol. 2002.
PMID: 11812095
Clinical Trial.